⚡️ What’s new in healthcare this week?

From GenAI regulation and GLP-1 battles to major healthcare acquisitions, breakthrough wearables, and the latest AI-powered advances in care and research, here’s your quick roundup of the week.

Peptides Platform provides the technology infrastructure for businesses looking to launch fast compliant peptide-based telehealth and healthcare services. The company develops integrated platforms that connect patient and provider portals, clinical intake and review, e-prescribing, pharmacy fulfillment, prescription-gated payments, laboratory monitoring, and patient engagement. Its goal is to help healthcare companies get to market fast and operate their own branded peptide platforms while maintaining control of their technology, data, and patient relationships.

---

Hey there Insider,

Hope you had a fantastic week!

Here’s your must-read weekly roundup of the latest news and developments in the digital healthcare sector! 👇🏼

1. FDA weighs regulatory approach for genAI medical devices.

2. Hims & Hers CEO says FTC lawsuit misunderstands how the company works.

3. DocGo to acquire virtual care company Hicuity Health.

4. Whoop expands Advanced Labs to non-members, adds Grail’s multi-cancer detection test to lineup.

5. Midi Health expands beyond menopause care with new brand identity.

6. Temple is now smallest wearable and ‘10^10’ more powerful, says Deepinder Goyal.

7. Bioptimus, Cancer Research Horizons partner on AI cancer model.

8. Epic bets on its AI speed at UGM.

9. Healthcare CFOs pursue margin gains as AI readiness gaps persist.

10. FDA-cleared medical AI rarely tested for real-world benefits.

August 12-14 | Montreal, Canada.
84th FIP World Congress of Pharmacy and Pharmaceutical Sciences

Until next week, stay connected!

Digital Health Insider.